Skip to Content
Get key facts and figures about chronic dry eye

Flurbiprofen ophthalmic Pregnancy and Breastfeeding Warnings

Flurbiprofen ophthalmic is also known as: Ocufen

Flurbiprofen ophthalmic Pregnancy Warnings

Animal studies have shown increased pre- and post-implantation loss and embryo-fetal lethality. Additionally, increased incidences of various malformations, including cardiovascular, have been reported. There are no adequate and well-controlled studies in pregnant women. AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

AU, US: Use should be avoided UK: Use should be avoided during the first two trimesters of pregnancy; use is contraindicated during the third trimester of pregnancy AU TGA pregnancy category: C US FDA pregnancy category: C Comments: -Studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. -If this drug is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low and duration of therapy as short as possible. -During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension), renal dysfunction (which may progress to renal failure with oligo-hydroamniosis). -All prostaglandin synthesis inhibitors may expose both the mother and the neonate to possible prolongation of bleeding time and the mother to inhibition of uterine contractions resulting in delayed or prolonged labor.

See references

Flurbiprofen ophthalmic Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. "Product Information. Ocufen Liquifilm (flurbiprofen)." Allergan Inc, Irvine, CA.

References for breastfeeding information

  1. "Product Information. Ocufen Liquifilm (flurbiprofen)." Allergan Inc, Irvine, CA.
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.